- Review
Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice
- Alessandro Gozzetti,
- Donatella Raspadori,
- Francesca Bacchiarri,
- Anna Sicuranza,
- Paola Pacelli,
- Ilaria Ferrigno,
- Dania Tocci and
- Monica Bocchia
Novel drugs have revolutionized multiple myeloma therapy in the last 20 years, with median survival that has doubled to up to 8–10 years. The introduction of therapeutic strategies, such as consolidation and maintenance after autologous stem cell tra...

